This scientific statement is a granular contribution to a major cardiovascular issue, illuminating nuances of the “generally recognized as safe” (GRAS) FDA designation. One would expect the relevant Thoracic Associations in North America and Europe to contribute to this debate.
You are here:
Cardiopulmonary Consequences of Vaping in Adolescents: A Scientific Statement From the American Heart Association
Submitted by: Aristotle Protopapas
Source: Circulation Research
Keywords:
Author(s): American Heart Association Council on Basic Cardiovascular Sciences; Council on Arteriosclerosis, Thrombosis, and Vascular Biology; Council on Hypertension; and Stroke Council
